Some patients describe it similarly to a metallic taste in mouth Mounjaro, especially during rapid or early weight loss phases
The lead authors of the study are Mahesh Umapathysivam, MBBS, DPhil, an endocrinologist and clinical researcher at Adelaide University in Australia and a former trainee with Gloyn, and Elisa Araldi, PhD, associate professor of medicine and surgery at the University of Parma in Italy and a former trainee with Stoffel
Neutralizing antibodies against these cytokines have been shown to delay ferroptosis amplification and provide neuroprotection in animal models, indicating potential clinical applicability (Deng et al., 2023)
Mechanism of Action (Based on Research) Preclinical studies suggest Semaglutide (GLP-1) may influence: Regulates appetite signals in the brain Slows gastric emptying, promoting satiety Supports blood glucose regulation Influences metabolic pathways Important: FDA-approved semaglutide (Wegovy) clinical trials showed participants lost an average of 12.4% of initial body weight over 68 weeks
